Y-mAbs Therapeutics (YMAB) Tops Q2 EPS by 10c, beats revenue, offers guidance

Go back to Y-mAbs Therapeutics (YMAB) Tops Q2 EPS by 10c, beats revenue, offers guidance
(NASDAQ: YMAB) Delayed: 8.61 --0 (-0%)
Previous Close $8.61    52 Week High
Open $8.61    52 Week Low
Day High $8.61    P/E N/A 
Day Low $8.61    EPS
Volume 4,643,403